Please use a PC Browser to access Register-Tadawul
OKYO Pharma Moves At-The-Market Equity Offering Facility To Leerink
OKYO Pharma Limited -1.78% Post
OKYO Pharma Limited OKYO | 1.66 1.66 | -1.78% 0.00% Post |
The ATM facility provides OKYO Pharma the ability to raise capital opportunistically while minimizing market disruption. Sales under the program, if any, will be made pursuant to a prospectus supplement and accompanying base prospectus filed with the U.S. Securities and Exchange Commission (SEC). Leerink Partners will act as the exclusive sales agent and receive a commission equal to 3.0% of gross proceeds from any shares sold.


